Abbott Laboratories Tricor Fails Main Goal In Diabetes Trial

Abbott Laboratories Inc.'s drug to lower blood fats called triglycerides failed its primary goal in a large trial of significantly reducing heart attacks and coronary deaths among patients with type II diabetes, researchers said on Monday.